Elizabeth Holt
iOnctura has appointed Elizabeth Holt as Chief Business Officer
Read More
Tag: ionctura
iOnctura’s roginolisib awarded Innovation Passport
MHRA designation involves entry into innovative licensing and access pathway
Read More
iOnctura reveals roginolisib research results
Therapy prevents tumour proliferation while breaking immune tolerance among cancer patients
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
